Drug Pipeline

Gocatamig Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
2
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 1/2
3
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06780137 A Study to Evaluate the Safety and Efficacy of Gocatamig (MK-6070) and Ifinatamab… Small Cell Lung Cancer Recruiting
NCT07227597 A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People… Small Cell Lung Cancer Extensive Stage Recruiting
NCT04471727 A Study in Participants With Advanced Cancers Associated With Expression of DLL3… Small-Cell Lung Cancer Active, Not Recruiting
Sponsors Running Gocatamig Trials
Merck Sharp & Dohme LLC (2) Harpoon Therapeutics, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) (1)
Disease Areas
Lung Cancer (3) Small Cell Lung Cancer (2)
Get alerts when Gocatamig trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free